PANACEABIO388.00

Panacea Biotec Limited

· Pharma & Health
₹ CrorePeersSAIPARENTHIKALINDOCODCALWINDLASHESTERBIOSOLARASYNCOMFMcap ₹2,378 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
PANACEABIO
FY26
SAIPARENT
FY26
HIKAL
FY26
INDOCO
FY26
Peer
Median
Valuation — at last close
P/E119.50×119.50×
P/B2.87×4.65×2.41×2.55×2.55× +12%
EV/EBITDA-501.02×56.96×16.16×23.92×23.92× -2195%
Market Cap₹2,378 Cr₹2,302 Cr₹2,891 Cr₹2,381 Cr₹2,381 Cr -0%
Growth
Revenue CAGR 3Y11.63%-5.40%3.41%-1.00% +1269%
Revenue CAGR 5Y0.47%-0.09%8.25%4.08% -88%
Revenue YoY (latest Q)19.72%5.89%6.76%6.32% +212%
Net Income YoY (latest Q)-44.44%66.96%280.03%173.49% -126%
Profitability
EBITDA Margin-0.73%10.16%12.87%7.68%10.16% -107%
Net Income Margin-1.12%3.74%-2.85%-5.35%-2.85% +61%
Return on Common Equity-0.65%2.88%-4.07%-10.21%-4.07% +84%
Return on Capital Employed-4.13%2.57%3.36%1.00%2.57% -261%
Return on Assets-0.57%1.00%-2.06%-3.81%-2.06% +72%
Credit & Quality
Total Debt/Equity0.03×0.65×0.57×1.11×0.65× -95%
Interest Coverage-6.23×1.18×0.91×0.13×0.91× -785%
Scale — latest FY
Revenue / Total Income₹640 Cr₹381 Cr₹1,713 Cr₹1,845 Cr₹1,713 Cr -63%
Net Income−₹7.2 Cr₹14.3 Cr−₹48.8 Cr−₹98.7 Cr−₹48.8 Cr +85%
Total Assets₹1,262 Cr₹1,424 Cr₹2,365 Cr₹2,593 Cr₹2,365 Cr -47%
EPS₹-0.88₹4.36₹-3.96₹-10.7₹-3.96 +78%
Book Value per Share₹135.22₹112.07₹97.07₹100.99₹100.99 +34%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.